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ABSTRACT
Objective To examine associations between Neisseria 
gonorrhoeae (NG) infection during pregnancy and the 
risk of preterm birth, spontaneous abortion, premature 
rupture of membranes, perinatal mortality, low birth 
weight and ophthalmia neonatorum.
Data sources We searched Medline, EMBASE, the 
Cochrane Library and Cumulative Index to Nursing and 
Allied Health Literature for studies published between 
1948 and 14 January 2020.
Methods Studies were included if they reported testing 
for NG during pregnancy and compared pregnancy, 
perinatal and/or neonatal outcomes between women 
with and without NG. Two reviewers independently 
assessed papers for inclusion and extracted data. Risk 
of bias was assessed using established checklists for 
each study design. Summary ORs with 95% CIs were 
generated using random effects models for both crude 
and, where available, adjusted associations.
Results We identified 2593 records and included 30 
in meta- analyses. Women with NG were more likely to 
experience preterm birth (OR 1.55, 95% CI 1.21 to 1.99, 
n=18 studies); premature rupture of membranes (OR 
1.41, 95% CI 1.02 to 1.92, n=9); perinatal mortality 
(OR 2.16, 95% CI 1.35 to 3.46, n=9); low birth weight 
(OR 1.66, 95% CI 1.12 to 2.48, n=8) and ophthalmia 
neonatorum (OR 4.21, 95% CI 1.36 to 13.04, n=6). 
Summary adjusted ORs were, for preterm birth 1.90 
(95% CI 1.14 to 3.19, n=5) and for low birth weight 
1.48 (95% CI 0.79 to 2.77, n=4). In studies with 
a multivariable analysis, age was the variable most 
commonly adjusted for. NG was more strongly associated 
with preterm birth in low- income and middle- income 
countries (OR 2.21, 95% CI 1.40 to 3.48, n=7) than in 
high- income countries (OR 1.38, 95% CI 1.04 to 1.83, 
n=11).
Conclusions NG is associated with a number of 
adverse pregnancy and newborn outcomes. Further 
research should be done to determine the role of NG 
in different perinatal mortality outcomes because 
interventions that reduce mortality will have the greatest 
impact on reducing the burden of disease in low- income 
and middle- income countries.
PROSPERO registration number CRD42016050962.
INTRODUCTION
Sexually transmitted infections (STIs) during preg-
nancy have been reported to be associated with 
poor pregnancy outcomes.1–3 Neisseria gonorrhoeae 
(NG) has been associated with premature rupture 
of membranes (PROM),1 preterm birth (PTB),1 4 5 
low birth weight (LBW),1 4–6 neonatal and perinatal 
mortality7 8 as well as neonatal conjunctivitis.9 10
Preterm birth and its complications are a leading 
cause of perinatal mortality and the majority 
of perinatal and neonatal deaths occur in low- 
resource settings.11 12 Information about associa-
tions between NG during pregnancy and adverse 
pregnancy and birth outcomes is therefore neces-
sary to improve our understanding of the evidence 
for causality, and to determine the potential impact 
of preventive interventions.1 13
To date, systematic reviews about adverse preg-
nancy and birth outcomes have examined, and 
found, associations with Chlamydia trachomatis 
(CT),14–16 Trichomonas vaginalis (TV)17 and Myco-
plasma genitalium (MG).18 The objective of this 
study was to systematically review associations 
between NG infection during pregnancy and the 
risk of PTB, spontaneous abortion, PROM, peri-
natal mortality, LBW and ophthalmia neonatorum.
METHODS
The protocol for this review has been published.19 
We report our findings using the Preferred 
Reporting Items for Systematic Reviews and Meta- 
Analyses (online supplemental table S1).20
Eligibility criteria
Studies reporting NG detected by culture and/or 
nucleic acid amplification test during pregnancy, 
labour or post partum were eligible for inclusion 
if they reported on one or more of the following 
outcomes: PTB, spontaneous abortion, PROM 
(preterm and term), LBW, perinatal or neonatal 
mortality, or ophthalmia neonatorum. We included 
clinical trials, cohort, case- control and cross- 
sectional studies but excluded individual case 
reports, case series, opinion articles and studies 
without a comparison group.
Information sources and search strategy
We searched Medline, Excerpta Medica database 
(EMBASE), the Cochrane Library and Cumula-
tive Index to Nursing and Allied Health Litera-
ture (CINAHL) from 1948 to 14 January 2020. 
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or relevant reviews for additional articles. The searches did 
not apply language restrictions, but we included only articles 
published in English or German (languages spoken fluently by 
review team members). Details of the search strategy are listed 
in online supplemental text S1.
Study selection and data extraction
One reviewer (LV) screened titles and abstracts (online supple-
mental text S2) and two reviewers screened the full text of 
potentially relevant articles independently (LV, DE- G). Discrep-
ancies were resolved by discussion or by the decision of a third 
reviewer (NL). Data were extracted into a standardised, piloted 
form in a Research Electronic Data Capture (REDCap) database 
(Vanderbilt University, Tennessee, USA) recording study design, 
participant characteristics, presence or absence of NG, preg-
nancy, perinatal or neonatal outcomes and other STI and genital 
infections. Standard definitions for outcomes were used,19 or as 
defined by the authors (online supplemental tables S2−S4).
Risk of bias in individual studies
Two reviewers assessed the risk of bias in each study inde-
pendently (LV, DE- G), using checklists for cross- sectional,21 
case- control and cohort studies,22 published by the UK National 
Institute for Health and Care Excellence (NICE). A third 
reviewer (NL) resolved discrepancies. Each study was assessed 
qualitatively overall as having all or most (++), some (+), or 
few or no checklist criteria fulfilled (−).
Data synthesis and analysis
We used Stata V.14.0 (StataCorp, College Station, Texas, USA) 
for all analyses. Where possible, we used the odds ratio (OR) as 
the measure of association for all study designs, assuming that the 
relative risk (RR) and OR would be similar, as the outcomes of 
interest are rare events. We calculated the crude OR and its 95% 
CI using raw data from the paper, or extracted values provided 
by the authors if raw data were not available. Where authors 
reported a multivariable analysis, we extracted the adjusted OR 
(aOR, 95% CI) and recorded the variables included in the model. 
We examined forest plots for each outcome ((figures 1 and 2; 
online supplemental tables S3−S10), and used the I2 statistic to 
examine the level of between- study heterogeneity other than 
that due to chance.23
For outcomes reported by two or more studies of the same 
design, we used a random effects model to estimate a summary 
OR (95% CI), which is the average effect across all included 
studies.24 We first stratified these estimates by study design 
because there are sources of bias that could result in overestima-
tion or underestimation of an association and these biases differ 
according to the study design. If the stratified estimates were 
similar, as visualised in forest plots, we also reported the overall 
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summary OR from meta- analysis, with its prediction interval for 
the estimated range of effect sizes across settings.24 Meta- analysis 
of the results of aORs used the same approach as for unadjusted 
estimates. For the outcome PTB, for which there were >10 
included studies, we categorised studies as high- income and 
non- high- income (combining low- income and middle- income 
countries), based on the World Bank list.25 We repeated all meta- 
analyses using a fixed effects model as a sensitivity analysis.
Risk of bias across studies
Publication bias was examined by generating a funnel plot for 
outcomes that were reported by 10 or more studies.
RESULTS
In total, 2914 records were identified and 2593 screened, 
after exclusion of duplicates. Eighty- five full- text articles were 
assessed and 33 studies were included, with 30 reporting data 
in a format suitable for meta- analysis (online supplemental 
figure S1). Three studies were excluded from meta- analyses 
because of zero counts or missing data,26–28 another three 
studies reported on more than one outcome but had suffi-
cient data for only one outcome (online supplemental table 
S5).29–31 The 33 studies reported on 60 outcomes. Twenty- one 
studies reported PTB,4–8 27–29 31–43 3 reported spontaneous 
abortion,34 41 44 12 reported PROM,6 8 26 29–31 34 40 41 43 45 46 9 
reported perinatal mortality outcomes,7 8 28 30 34 35 41 47 48 8 
reported LBW4 6 7 35 37 40 42 49 and 7 reported ophthalmia neona-
torum7 9 26 42 50–52 (online supplemental tables S2- S4).
We included 14 cohort, 11 case- control and 8 cross- sectional 
studies published between 1976 and January 2020. The number 
of outcomes reported varied from 6236 to 31 720.43 Two- thirds 
(22/33) of studies took place in high- income and upper middle- 
income settings (table 1; online supplemental tables S2- S4); most 
took place in health facilities (28/33) and more than half were in 
urban locations (19/33). Thirteen studies reported participant’s 
age, 23 ethnicity, 6 smoking status and 4 reported multiple 
pregnancies (full descriptive details are available in online 
supplemental tables S6- S8).
Characteristics of specimen collection, timing and labo-
ratory tests are reported in online supplemental tables S2- S4. 
Briefly, 25 studies reported the timing of specimen collec-
tion, of which 12 obtained specimens during pregnancy; 
29 30 32 34 36 37 43–45 48 50 52 2 collected specimens intrapartum;46 51 
5 post partum;6 9 38 42 49 3 during both the antenatal and post-
partum period;35 39 47 the remaining three studies tested during 
pregnancy or intrapartum,41 intrapartum or post partum7 and 
intrapartum and post partum.31 Most studies reported spec-
imen type (26), with 24 collecting endocervical and/or vaginal 
swabs.5 6 9 26 27 30–34 36–39 41 44–52 Twenty- nine reported type of 
laboratory test.4–9 26 27 29–39 41 42 44–47 49–52
Twenty studies reported provision of treatment at the time of 
NG diagnosis: 8 treated all positive women4 9 30 35 45 47 51 52; 12 
treated some women.5 8 26 32 34 37–39 41 42 44 49 Provision of treat-
ment was unclear in 12 studies6 7 27–29 31 33 36 40 43 46 48 and 1 study 
did not provide treatment50 (online supplemental tables S9- S11).
Most studies (29) tested for other STI and genital 
infections: 6 tested for BV,4 6 33 36 47 52 25 tested for 
CT,4–7 9 27–36 38–40 42 43 45–47 50 52 9 tested for HIV,4 6 7 35 44 47–49 52 5 
tested for MG,27 32–34 38 14 tested for syphilis4–7 26 33 39 40 43 44 47–49 52 
and 10 tested for TV4 27 28 33 35 38 39 46 47 52 (online supplemental 
tables S9- S11).
Risk of bias
Based on the NICE checklists, of the 33 studies, 2 met 
all or most (++) checklist criteria,4 7 7 met all/ most or 
some (++/+),6 29 35 38 40 43 47 10 studies met some (+) 
criteria,8 27 32 33 44–46 48 49 52 7 met some or few/no criteria 
(+/−),9 28 34 37 39 50 51 and 7 met few or no checklist criteria 
(−)5 26 30 31 36 41 42 (table 1, online supplemental tables S12- S14). 
There was evidence of publication bias and other small study 
effects (Egger’s test, p=0.008) for the association between NG 
and preterm birth (online supplemental figure S2).
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Preterm birth
Twenty- one studies reported on the association between NG 
in pregnancy and PTB. Eighteen studies involving at least 
60 396 women were included in meta- analysis; nine cohort 
studies,5 7 29 32–37 six case- control4 6 8 38–40 and three cross- 
sectional studies.41–43 The overall unadjusted summary OR for 
NG and PTB was 1.55 (95% CI 1.21, 1.99; I2 61.1%; prediction 
interval 0.72, 3.35) (figure 1, table 2). Eleven studies were from 
high- income countries4 8 29 32–34 37 39 41 43 45 (table 1). NG was 
more strongly associated with PTB in non- high- income coun-
tries (OR 2.21, 95% CI 1.40 to 3.48; I2 14.7%) than in high- 
income countries (OR 1.38, 95% CI 1.04 to 1.83; I2 68.6%) 
(online supplemental figures S3, S4).
In five studies, multivariable analysis was conducted. The vari-
ables adjusted for differed between studies (online supplemental 
table S15). The summary aOR for NG and PTB was 1.90 (95% 
CI 1.14 to 3.19; I2 64.5%; overall prediction interval 0.36 to 
10.03) (figure 2, table 2).
Spontaneous abortion
Three studies involving 6329 women reported on spontaneous 
abortion.34 41 44 All three were different study designs, and none 
reported a multivariable analysis. There was insufficient informa-
tion from these studies to determine the strength of association 
between NG and spontaneous abortion (online supplemental 
figure S5).
Premature rupture of membranes
Twelve studies reported on the association between NG in preg-
nancy and PROM; three cohort,26 29 34 five case- control6 8 30 40 45 
and four cross- sectional studies.31 41 43 46 Nine studies involving 
42 168 women were included in the meta- analysis.6 8 31 34 40 41 43 45 46 
The unadjusted summary OR for NG and PROM was 1.41 (95% 
CI 1.02 to 1.92; I2 59.2%; prediction interval 0.64 to 3.11) 
(table 2, online supplemental figure S6). None of the included 
studies reported a multivariable analysis.
Perinatal mortality
Nine studies involving 21 854 women examined perinatal 
mortality outcomes: six cohort,7 34 35 37 47 48 two case- control8 30 
and one cross- sectional study.41 Of these, two reported neonatal 
mortality,7 30 two perinatal mortality,8 41 three stillbirths34 35 48 
and two reported on both stillbirths and neonatal mortality.37 47 
The unadjusted summary OR for NG and any perinatal mortality 
outcome was 2.16 (95% CI 1.35 to 3.46; I2 40.3%, prediction 
interval 0.69 to 6.74) (table 2, online supplemental figure S7). 
Two studies conducted a multivariable analysis for stillbirth. 
Moodley et al adjusted for age, number of pregnancies, socio-
economic status, HIV-1, CT and TV infection.35 The aOR was 
the same as the unadjusted OR (2.2; 95% CI 1.0 to 4.9). Kupka et 
al adjusted for gestational age, maternal literacy, history of still-
birth, CD4 count and previous hospitalisation.48 They reported 
relative risks and found a stronger association in the adjusted 
than the unadjusted model (9.74, 95% CI 2.52 to 37.59 vs 7.58, 
95% CI 1.33 to 43.28), but CIs were wide and overlapping.
Low birth weight
Eight studies involving at least 18 844 infants reported LBW: 
four cohort,7 35 37 49 three case- control4 6 40 and one cross- 
sectional study.42 The summary unadjusted OR for the associa-
tion between NG and LBW was 1.66 (95% CI 1.12 to 2.48; I2 
72.7%; prediction interval 0.51 to 5.38) (table 2, online supple-
mental figure S8). Five studies reported multivariable anal-
yses.4 6 35 40 49 The studies adjusted for different variables, only 
four provided enough details to include in meta- analysis4 6 35 40 
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†Study not included in meta- analysis.
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  Adjusted 5 1.90 (1.14 to 3.19) 64.5 0.36 to 10.03
  Unadjusted 18 1.55 (1.21 to 1.99) 61.1 0.72 to 3.35
Low birth weight
  Adjusted 4 1.48 (0.79 to 2.77) 49.5 0.14 to 15.70
  Unadjusted 8 1.66 (1.12 to 2.48) 72.7 0.51 to 5.38
Premature rupture of 
membrane
9 1.41 (1.02 to 1.92) 59.2 0.64 to 3.11
Spontaneous abortion* 3 NA NA NA
Perinatal mortality 9 2.16 (1.35 to 3.46) 40.3 0.69 to 6.74
Ophthalmia neonatorum 6 4.21 (1.36 to 13.04) 58.0 0.17 to 104.58
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(95% CI 0.79 to 2.77; I2 64.5%; prediction interval 0.14 to 
15.70) (table 2; online supplemental figure S9).
Ophthalmia neonatorum
Seven studies reported on the association between NG and 
ophthalmia neonatorum: three cohort,7 9 26 three cross- 
sectional42 50 51 and one case- control study.52 One was excluded 
from meta- analysis as there were no events. The six studies 
included in the meta- analysis involved at least 3741 infants. The 
unadjusted summary OR for NG and ophthalmia neonatorum 
was 4.21 (95% CI 1.36 to 13.04; I2 58%; prediction interval 
0.17 to 104.58) (table 2, online supplemental figure S10). None 
of the included studies reported a multivariable analysis.
Sensitivity analysis
Sensitivity analysis was undertaken for all outcomes. Effect esti-
mates from fixed effect meta- analyses were similar to those from 
random effects models but tended to be slightly lower (online 
supplemental table S16).
DISCUSSION
This systematic review included 33 studies for the qualita-
tive analysis and 30 studies for meta- analysis. In studies that 
controlled for potential confounding, NG during pregnancy 
was associated with an increase in the adjusted odds of PTB of 
1.90 (95% CI 1.14 to 3.19, five studies) and in the adjusted 
odds of LBW of 1.48 (95% CI 0.79 to 2.77, four studies). The 
odds of PROM, perinatal mortality and ophthalmia neonatorum 
were also increased in women with NG, but most studies of 
these outcomes did not provide estimates that controlled for 
confounding. There was insufficient evidence from studies of 
spontaneous abortion. The association between NG in preg-
nancy and PTB was stronger in studies conducted in low- income 
and middle- income countries than in high- income countries.
The main strength of this review was the use of a protocol19 
to define the outcomes and analyses in advance and independent 
work by two reviewers to reduce bias in study selection, data 
extraction and risk of bias assessment. An additional strength 
is the calculation of prediction intervals for the summary esti-
mates.24 With random effects meta- analysis, the summary OR 
is an average of the effect estimate and its 95% CI. The predic-
tion interval gives information about the range of effect sizes 
across the settings in which studies included in the review were 
conducted.24 We combined effect estimates from different study 
designs if the stratified summary estimates were similar. The 
biases affecting individual studies and each observational study 
design differ, with some likely to overestimate the strength of 
association and others likely to underestimate it. Triangulation 
of findings across study designs is a strength of this review. 
Consistency in the direction and strength of effects can increase 
confidence in a causal interpretation, if confounding is addressed 
adequately.53 There are also weaknesses in the review methods. 
Despite searching multiple databases, our search strategy might 
have missed relevant studies, for example, in languages other 
than English or German.
Our searches did not find any other systematic review of the 
association between NG and adverse pregnancy outcomes. In 
narrative reviews, the findings tend to group different adverse 
outcomes together and to cite those from studies that find the 
strongest associations.1 54 The advantage of this review is the 
systematic inclusion of all eligible studies and examination of 
evidence separately for each outcome.
Our findings suggest that NG in pregnancy increases the risk of 
PTB and LBW. The certainty of evidence for causal associations is 
challenged by confounding and bias.55 In all observational study 
designs, confounding is an issue so the confounder- adjusted effect 
estimates are of most interest.53 In this systematic review, PTB 
and LBW were the only outcomes for which there were enough 
included studies to estimate a confounder- adjusted summary 
OR. For PTB, the summary aOR (1.90, 95% CI 1.14 to 3.19) 
was higher than the unadjusted OR, but the wide CI included 
the unadjusted summary estimate. For LBW, the 95% CI for the 
summary aOR (1.48, 95% CI 0.79 to 2.77) was compatible with 
there being no increased risk of LBW, but might reflect the small 
number of studies. The presence of co- infections, especially HIV, 
could also confound these associations. All studies reporting 
the outcomes PTB and LBW reported testing for other genital 
infections, but only Moodley et al, reporting from a high- burden 
setting, adjusted for co- infections (CT, TV and HIV)35 for these 
two outcomes. In that study, adjustment did not change the 
effect size. Of the other 18 studies reporting PTB and/or LBW, 
15 reported co- infection with CT, four with TV and four with 
HIV. Each of these infections has been reported to be associated 
with LBW14 15 56 and PTB.15 17 56 Measurement bias might also 
have resulted in underestimation of the strength of association 
because, in most studies, women with NG had received treat-
ment. These studies are measuring the outcome of treated NG, 
when the causal association of interest is with untreated NG.55 In 
this situation, cross- sectional studies that measure the presence 
of NG at the time of delivery are assessing the association with 
untreated infection. Although the onset of infection is unknown, 
adjusted estimates from such studies might be less biased than 
some cohort and case- control studies.55
For spontaneous abortion there were only three studies, with 
insufficient evidence to determine whether there is an associa-
tion with NG. The association with ophthalmia neonatorum was 
strong and is known to be causal because there is evidence from 
randomised controlled trials that effective antiseptic or anti-
microbial treatment prevents the condition.57 The association 
with perinatal mortality outcomes deserves further investigation 
to determine whether it is a consequence of PTB and LBW, or 
whether NG is an independent risk factor. The potential mech-
anisms linking NG to adverse perinatal outcomes are not well 
understood but NG might cause low- grade inflammation of the 
placenta and fetal membranes, increasing the risk of chorioam-
nionitis and thus PROM and PTB.58 If placental inflammation 
or infection of the amniotic cavity are implicated in the patho-
genesis of PTB, the timing of NG infection and treatment during 
pregnancy might modify the risk. There was insufficient data 
in the included studies to formally examine the effects of these 
factors in the meta- analyses.
Future studies to investigate the role of NG as a cause of 
adverse pregnancy outcomes should be designed to address the 
limitations of many of the studies in this review. First, observa-
tional studies should collect data about potential confounding 
factors and be large enough to conduct multivariable analyses. 
Second, if treatment is given, the timing should be recorded so 
that study findings can be interpreted with this information. 
Third, samples should be taken for other STIs and vaginal micro-
biota so that the role of co- infections can be better understood. 
Randomised controlled trials are one way to examine the causal 
role of NG. Several trials of screening and treatment interven-
tions are underway.59 60 However, it will be difficult to determine 
the effect of NG alone, because the interventions often include 
treatment for multiple infections. These trials are taking place 




































110 Vallely LM, et al. Sex Transm Infect 2021;97:104–111. doi:10.1136/sextrans-2020-054653
Review
of STIs and of adverse pregnancy outcomes is highest.11 12 Our 
review also found that the strength of association between NG 
and PTB was greater in low- income and middle- income than 
in high- income settings. In summary, this review suggests that 
NG is causally associated with PTB and LBW. Further research 
should be done to determine the role of NG in different perinatal 
mortality outcomes because interventions that reduce mortality 
will have the greatest impact on reducing the burden of disease 
in low- income and middle- income countries.
Key messages
 ► Women with Neisseria gonorrhoeae (NG) in pregnancy are 
more likely to experience adverse birth outcomes including 
preterm birth, premature rupture of membranes, low birth 
weight, perinatal mortality and ophthalmia neonatorum.
 ► NG was more strongly associated with preterm birth in low- 
income and middle- income countries than in high- income 
countries.
 ► Further studies are required to address the gap in evidence 
about the effects of testing and treatment of NG in 
pregnancy, particularly in low- income and middle- income 
settings.
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